Advanced hemodynamic monitoring before and after transjugular intrahepatic portosystemic shunt: Implications for selection of patients - A prospective study

Radiology

Volumn 262, Issue 1, 2012, Pages 343-352

  Saugel, Bernd ^a   Phillip, Veit ^a   Gaa, Jochen ^a   Berger, Hermann ^a   Lersch, Christian ^a   Schultheiss, Caroline ^a   Thies, Philipp ^a   Schneider, Heike ^a   Höllthaler, Josef ^a   Herrmann, Andrea ^a   Schmid, Roland M ^a   Huber, Wolfgang ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOLOGICAL MARKER; CREATININE; CYSTATIN C; INDOCYANINE GREEN; NITROGEN; UREA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD ANALYSIS; CARDIOVASCULAR FUNCTION; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; HEART INDEX; HEART VOLUME; HEMODYNAMIC MONITORING; HEMODYNAMIC PARAMETERS; HUMAN; INTERNATIONAL NORMALIZED RATIO; KIDNEY FUNCTION; LIVER FUNCTION; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT SELECTION; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRESSURE GRADIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; THERAPY EFFECT; THERMODILUTION; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT INDICATION; UREA NITROGEN BLOOD LEVEL; VASCULAR RESISTANCE;

AGED; BIOLOGICAL MARKERS; FEMALE; HEMODYNAMICS; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; LINEAR MODELS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; PATIENT SELECTION; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROSPECTIVE STUDIES; ROC CURVE; STATISTICS, NONPARAMETRIC; STENTS; THERMODILUTION; TREATMENT OUTCOME;

EID: 84455206449     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11110043     Document Type: Article

References (34)

1. García-Pagán JC, Caca K, Bureau C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010;362(25):2370-2379.
2. Jalan R, Forrest EH, Stanley AJ, et al. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology 1997;26(5):1115-1122. (Pubitemid 27509291)
3. Salerno F, Cammà C, Enea M, Rössle M, Wong F. Transjugular intrahepatic portosystemic shunt for refractory ascites: a metaanalysis of individual patient data. Gastroenterology 2007;133(3):825-834. (Pubitemid 47374134)
4. Guevara M, Ginès P, Bandi JC, et al. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology 1998;28(2):416-422. (Pubitemid 28363668)
5. Crippin JS, Schmidt RD, Niblett RL, Rees CR. Effect of a transjugular intrahepatic portosystemic shunt on liver biochemical profiles. J Vasc Interv Radiol 1995;6(3):461-464.
6. Rössle M, Gerbes AL. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update. Gut 2010;59(7):988-1000.
7. Sanyal AJ, Freedman AM, Shiffman ML, Purdum PP 3rd, Luketic VA, Cheatham AK. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 1994;20(1 Pt 1):46-55. (Pubitemid 24196490)
8. Braverman AC, Steiner MA, Picus D, White H. High-output congestive heart failure following transjugular intrahepatic portal-systemic shunting. Chest 1995;107(5):1467-1469.
9. Huonker M, Schumacher YO, Ochs A, Sorichter S, Keul J, Rössle M. Cardiac function and haemodynamics in alcoholic cirrhosis and effects of the transjugular intrahepatic portosystemic stent shunt. Gut 1999;44(5):743-748. (Pubitemid 29195928)
10. Møller S, Henriksen JH. Cardiovascular complications of cirrhosis. Gut 2008;57(2):268-278. (Pubitemid 351158057)
11. Reuter DA, Felbinger TW, Schmidt C, et al. Stroke volume variations for assessment of cardiac responsiveness to volume loading in mechanically ventilated patients after cardiac surgery. Intensive Care Med 2002;28(4):392-398. (Pubitemid 34328021)
12. Fernández-Mondéjar E, Rivera-Fernández R, García-Delgado M, Touma A, Machado J, Chavero J. Small increases in extravascular lung water are accurately detected by transpulmonary thermodilution. J Trauma 2005;59(6):1420-1423; discussion 1424.
13. Fincke R, Hochman JS, Lowe AM, et al. Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol 2004;44(2):340-348. (Pubitemid 38950593)
14. Sakka SG, Koeck H, Meier-Hellmann A. Measurement of indocyanine green plasma disappearance rate by two different dosages. Intensive Care Med 2004;30(3):506-509. (Pubitemid 38375630)
15. Sakka SG, Rühl CC, Pfeiffer UJ, et al. Assessment of cardiac preload and extravascular lung water by single transpulmonary thermodilution. Intensive Care Med 2000;26(2):180-187. (Pubitemid 30186592)
16. Saugel B, Ringmaier S, Holzapfel K, et al. Physical examination, central venous pressure, and chest radiography for the prediction of transpulmonary thermodilution-derived hemodynamic parameters in critically ill patients: a prospective trial. J Crit Care 2011;26(4):402-410.
17. Rössle M, Haag K, Ochs A, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994;330(3):165-171. (Pubitemid 24026884)
18. Boyer TD, Haskal ZJ;American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009. Hepatology 2010;51(1):306.
19. Haskal ZJ, Martin L, Cardella JF, et al. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. J Vasc Interv Radiol 2003;14(9 Pt 2):S265-S270.
20. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31(4):864-871. (Pubitemid 30169932)
21. Angermayr B, Cejna M, Karnel F, et al. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut 2003;52(6):879-885. (Pubitemid 36613497)
22. Montgomery A, Ferral H, Vasan R, Postoak DW. MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures. Cardiovasc Intervent Radiol 2005;28(3):307-312. (Pubitemid 40880749)
23. Salerno F, Merli M, Cazzaniga M, et al. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt. J Hepatol 2002;36(4):494-500. (Pubitemid 34407337)
24. Schepke M, Roth F, Fimmers R, et al. Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting. Am J Gastroenterol 2003;98(5):1167-1174. (Pubitemid 36733783)
25. Gülberg V, Haag K, Rössle M, Gerbes AL. Hepatic arterial buffer response in patients with advanced cirrhosis. Hepatology 2002;35(3):630-634. (Pubitemid 34183968)
26. Radeleff B, Sommer CM, Heye T, et al. Acute increase in hepatic arterial flow during TIPS identified by intravascular flow measurements. Cardiovasc Intervent Radiol 2009;32(1):32-37.
27. Willoughby PH, Beers RA, Murphy KD. Pulmonary edema after transjugular intrahepatic portosystemic shunt. Anesth Analg 1996;82(4):895-896. (Pubitemid 26111613)
28. Møller S, Søndergaard L, Møgelvang J, Henriksen O, Henriksen JH. Decreased right heart blood volume determined by magnetic resonance imaging: evidence of central underfilling in cirrhosis. Hepatology 1995;22(2):472-478.
29. Henriksen JH, Bendtsen F, Sørensen TI, Stadeager C, Ring-Larsen H. Reduced central blood volume in cirrhosis. Gastroenterology 1989;97(6):1506-1513. (Pubitemid 20004177)
30. Umgelter A, Wagner K, Reindl W, Nurtsch N, Huber W, Schmid RM. Haemodynamic effects of plasma-expansion with hyperoncotic albumin in cirrhotic patients with renal failure: a prospective interventional study. BMC Gastroenterol 2008;8 : 39.
31. Umgelter A, Reindl W, Wagner KS, et al. Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial. Crit Care 2008;12(1):R4.
32. Ochs A, Rössle M, Haag K, et al. The transjugular intrahepatic portosystemic stentshunt procedure for refractory ascites. N Engl J Med 1995;332(18):1192-1197.
33. Rajan DK, Haskal ZJ, Clark TW. Serum bilirubin and early mortality after transjugular intrahepatic portosystemic shunts: results of a multivariate analysis. J Vasc Interv Radiol 2002;13(2 Pt 1):155-161. (Pubitemid 34160377)
34. Patel NH, Sasadeusz KJ, Seshadri R, et al. Increase in hepatic arterial blood flow after transjugular intrahepatic portosystemic shunt creation and its potential predictive value of postprocedural encephalopathy and mortality. J Vasc Interv Radiol 2001;12(11):1279-1284. (Pubitemid 33069789)